10.10
Exagen Inc stock is traded at $10.10, with a volume of 495.16K.
It is up +1.20% in the last 24 hours and up +45.53% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$9.98
Open:
$9.98
24h Volume:
495.16K
Relative Volume:
1.79
Market Cap:
$222.24M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-10.74
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+6.43%
1M Performance:
+45.53%
6M Performance:
+182.12%
1Y Performance:
+231.15%
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XGN
Exagen Inc
|
10.10 | 214.54M | 52.55M | -23.69M | -15.29M | -0.94 |
![]()
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jul-23-25 | Initiated | Craig Hallum | Buy |
Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-15-21 | Resumed | Cowen | Outperform |
Apr-15-21 | Initiated | Canaccord Genuity | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Oct-08-20 | Initiated | BTIG Research | Buy |
Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cowen | Outperform |
Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
What recovery options are there for Exagen Inc.Portfolio Risk Report & Reliable Price Action Trade Plans - Newser
Best data tools to analyze Exagen Inc. stockEarnings Overview Report & Fast Gaining Stock Strategy Reports - Newser
Exagen Inc. stock trend forecastGold Moves & AI Forecast for Swing Trade Picks - Newser
Can technical indicators confirm Exagen Inc.’s reversalJuly 2025 Volume & Technical Entry and Exit Tips - Newser
Visual analytics tools that track Exagen Inc. performanceWeekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
Smart tools for monitoring Exagen Inc.’s price actionOil Prices & AI Optimized Trading Strategy Guides - Newser
Top chart patterns to watch in Exagen Inc.July 2025 Macro Moves & High Accuracy Investment Signals - Newser
Why Exagen Inc. stock attracts strong analyst attentionJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Is it time to cut losses on Exagen Inc.July 2025 Action & Fast Exit and Entry Strategy Plans - Newser
Exagen Inc. Breakout Confirmed by Volume MetricsMarket Movement Recap & Growth Focused Stock Pick Reports - newsyoung.net
What risks could impact Exagen Inc. stock performanceWeekly Market Outlook & Expert Verified Stock Movement Alerts - Newser
Exit strategy if you’re trapped in Exagen Inc.Weekly Stock Recap & AI Powered Trade Plan Recommendations - Newser
How to use a screener to detect Exagen Inc. breakoutsMarket Activity Summary & Accurate Entry/Exit Alerts - Newser
Why Exagen Inc. is moving todayWatch List & Fast Moving Stock Trade Plans - Newser
How to use Fibonacci retracement on Exagen Inc.July 2025 Macro Moves & Daily Growth Stock Investment Tips - Newser
Applying Elliott Wave Theory to Exagen Inc.Dollar Strength & Community Driven Trade Alerts - Newser
What makes Exagen Inc. stock price move sharplyQuarterly Earnings Summary & Long-Term Capital Growth Ideas - Newser
What’s next for Exagen Inc. stock priceShort Setup & Weekly Market Pulse Updates - Newser
What candlestick patterns are forming on Exagen Inc.Gap Up & Consistent Profit Focused Trading Strategies - Newser
Applying big data sentiment scoring on Exagen Inc.July 2025 Pullbacks & Stock Timing and Entry Methods - Newser
What to expect from Exagen Inc. in the next 30 daysMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Chart based analysis of Exagen Inc. trendsWeekly Volume Report & Verified Stock Trade Ideas - Newser
How Exagen Inc. stock performs during market volatilityInsider Buying & Low Risk Growth Stock Ideas - thegnnews.com
Price action breakdown for Exagen Inc.Bull Run & Stepwise Swing Trade Plans - Newser
Why is Exagen Inc. stock going downQuarterly Trade Review & High Accuracy Swing Trade Signals - newsyoung.net
Comparing Exagen Inc. in custom built stock radarsTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Applying chart zones and confluence areas to Exagen Inc.July 2025 Movers & Daily Volume Surge Signals - Newser
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exagen Inc Stock (XGN) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):